Department of Environmental Toxicology, University of California, Davis, CA 95616, USA.
Department of Earth and Environmental Sciences, University of Milano-Bicocca, 20126 Milan, Italy.
Int J Mol Sci. 2020 Apr 2;21(7):2474. doi: 10.3390/ijms21072474.
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the biological and toxicological effects of an AhR lacking the entire PASB structurally diverse chemicals, including halogenated aromatic hydrocarbons. Ligand-dependent transformation of the AhR into its DNA binding form involves a ligand-dependent conformational change, heat shock protein 90 (hsp90), dissociation from the AhR complex and AhR dimerization with the AhR nuclear translocator (ARNT) protein. The mechanism of AhR transformation was examined using mutational approaches and stabilization of the AhR:hsp90 complex with sodium molybdate. Insertion of a single mutation (F281A) in the hsp90-binding region of the AhR resulted in its constitutive (ligand-independent) transformation/DNA binding in vitro. Mutations of AhR residues within the Arg-Cys-rich region (R212A, R217A, R219A) and Asp371 (D371A) impaired AhR transformation without a significant effect on ligand binding. Stabilization of AhR:hsp90 binding with sodium molybdate decreased transformation/DNA binding of the wild type AhR but had no effect on constitutively active AhR mutants. Interestingly, transformation of the AhR in the presence of molybdate allowed detection of an intermediate transformation ternary complex containing hsp90, AhR, and ARNT. These results are consistent with a stepwise transformation mechanism in which binding of ARNT to the liganded AhR:hsp90 complex results in a progressive displacement of hsp90 and conversion of the AhR into its high affinity DNA binding form. The available molecular insights into the signaling mechanism of other Per-ARNT-Sim (PAS) domains and structural information on hsp90 association with other client proteins are consistent with the proposed transformation mechanism of the AhR.
芳香烃受体 (AhR) 是一种配体激活的转录因子,介导 AhR 的生物学和毒理学效应,而 AhR 缺乏整个 PASB 结构不同的化学物质,包括卤代芳烃。配体依赖性 AhR 向其 DNA 结合形式的转化涉及配体依赖性构象变化、热休克蛋白 90(hsp90)、与 AhR 复合物的解离以及 AhR 与 AhR 核转位蛋白(ARNT)蛋白的二聚化。使用突变方法和钼酸钠稳定 AhR:hsp90 复合物来检查 AhR 转化的机制。在 AhR 的 hsp90 结合区域插入单个突变(F281A)导致其在体外组成型(配体非依赖性)转化/DNA 结合。AhR 内 Arg-Cys 丰富区域(R212A、R217A、R219A)和 Asp371(D371A)的突变损害了 AhR 转化,而对配体结合没有显著影响。钼酸钠稳定 AhR:hsp90 结合降低了野生型 AhR 的转化/DNA 结合,但对组成型活性 AhR 突变体没有影响。有趣的是,钼酸盐存在下 AhR 的转化允许检测含有 hsp90、AhR 和 ARNT 的中间转化三元复合物。这些结果与逐步转化机制一致,其中 ARNT 与配体结合的 AhR:hsp90 复合物结合导致 hsp90 的逐渐置换和 AhR 向其高亲和力 DNA 结合形式的转化。其他 Per-ARNT-Sim(PAS)结构域的信号转导机制的现有分子见解以及 hsp90 与其他客户蛋白结合的结构信息与 AhR 转化机制一致。